Frédéric Triebel
Impact in
- Immunology top 0.2%
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 126
- T-cell and B-cell Immunology 85
- Immunotherapy and Immune Responses 45
- Immune Cell Function and Interaction 14
- Oncology 40
- Cancer Immunotherapy and Biomarkers 37
- Co-authors
- Thierry Hercend (53 shared papers)Setsuko Jitsukawa (15 shared papers)Bertrand Huard (8 shared papers)Florence Faure (19 shared papers)Sergio Roman‐Roman (12 shared papers)Catherine Genevée (12 shared papers)Denis Bruniquel (5 shared papers)Elena Baixerás (4 shared papers)
- Journals
- The Journal of Immunology (20 papers)European Journal of Immunology (18 papers)International Journal of Cancer (9 papers)The Journal of Experimental Medicine (8 papers)Annals of Oncology (7 papers)
- Partner nations
- FranceUnited KingdomSpain
In The Last Decade
Frédéric Triebel
160 papers receiving 9.8k citations
Frédéric Triebel's Hit Papers
Peers
Comparison fields: 5 of 93
- Immunology 4.7k
- Oncology 4.3k
- Virology 233
- Genetics 228
- Hematology 282
Countries citing papers authored by Frédéric Triebel
This map shows the geographic impact of Frédéric Triebel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Triebel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Triebel more than expected).
Fields of papers citing papers by Frédéric Triebel
This network shows the impact of papers produced by Frédéric Triebel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Triebel. The network helps show where Frédéric Triebel may publish in the future.
Co-authors
The 25 scholars most cited alongside Frédéric Triebel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 162 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | LAG-3, a novel lymphocyte activation gene closely related to CD4. Hit paper breakdown → | 1990 | 777 |
| 2 | 2015 | 404 | |
| 3 | 1992 | 351 | |
| 4 | 1995 | 336 | |
| 5 | 2010 | 302 | |
| 6 | 1997 | 256 | |
| 7 | 2011 | 225 | |
| 8 | 2010 | 212 | |
| 9 | 1998 | 208 | |
| 10 | 1994 | 205 | |
| 11 | 2009 | 193 | |
| 12 | 1987 | 185 | |
| 13 | 1994 | 167 | |
| 14 | 2005 | 167 | |
| 15 | 2007 | 166 | |
| 16 | 2002 | 161 | |
| 17 | 1989 | 149 | |
| 18 | 1991 | 139 | |
| 19 | 1987 | 138 | |
| 20 | 1994 | 138 |
About Frédéric Triebel
Frédéric Triebel is a scholar working on Immunology, Oncology, Hematology, Cancer Research and Otorhinolaryngology, having authored 162 papers that have together received 10.2k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (85 papers), Immunotherapy and Immune Responses (45 papers), Cancer Immunotherapy and Biomarkers (37 papers), Immune Cell Function and Interaction (14 papers), Hematopoietic Stem Cell Transplantation (7 papers), Breast Cancer Treatment Studies (7 papers), Renal cell carcinoma treatment (5 papers) and Head and Neck Cancer Studies (3 papers). The work is most often cited by research in Immunology (4.7k citations), Oncology (4.3k citations), Virology (233 citations), Genetics (228 citations) and Hematology (282 citations). Frédéric Triebel has collaborated with scholars based in France, United Kingdom and Spain. Frequent co-authors include Thierry Hercend, Setsuko Jitsukawa, Bertrand Huard, Florence Faure, Sergio Roman‐Roman, Catherine Genevée, Denis Bruniquel, Elena Baixerás, Chrystelle Brignone and Philippe Prigent. Their work appears in journals such as The Journal of Immunology, European Journal of Immunology, International Journal of Cancer, The Journal of Experimental Medicine and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.